Cargando…

Enhancement of tumor lethality of ROS in photodynamic therapy

In the process of photodynamic therapy (PDT) treatment of tumors, reactive oxygen species (ROS) plays a key role in destroying tumor tissues. However, traditional PDT often has limited ROS killing capacity due to hypoxia in the tumor microenvironment (TME) or obstruction by the ROS defense system, r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ming, Lan, Cheng, Kai, Chen, Yu, Yang, Rui, Chen, Daozhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826450/
https://www.ncbi.nlm.nih.gov/pubmed/33141513
http://dx.doi.org/10.1002/cam4.3592
_version_ 1783640523133681664
author Ming, Lan
Cheng, Kai
Chen, Yu
Yang, Rui
Chen, Daozhen
author_facet Ming, Lan
Cheng, Kai
Chen, Yu
Yang, Rui
Chen, Daozhen
author_sort Ming, Lan
collection PubMed
description In the process of photodynamic therapy (PDT) treatment of tumors, reactive oxygen species (ROS) plays a key role in destroying tumor tissues. However, traditional PDT often has limited ROS killing capacity due to hypoxia in the tumor microenvironment (TME) or obstruction by the ROS defense system, resulting in poor efficacy. Therefore, enhancing the killing effect of ROS on tumors is the core of enhancing the anti‐tumor effect of PDT. In recent years, many studies have developed a series of strategies to enhance the ability of ROS to kill tumors in view of the limitations of the TME on PDT. This article summarizes the commonly used or innovative strategies in recent years, including not only frequently used methods for hypoxia in the TME but also innovative strategies to inhibit the ROS defense system.
format Online
Article
Text
id pubmed-7826450
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78264502021-02-01 Enhancement of tumor lethality of ROS in photodynamic therapy Ming, Lan Cheng, Kai Chen, Yu Yang, Rui Chen, Daozhen Cancer Med Cancer Biology In the process of photodynamic therapy (PDT) treatment of tumors, reactive oxygen species (ROS) plays a key role in destroying tumor tissues. However, traditional PDT often has limited ROS killing capacity due to hypoxia in the tumor microenvironment (TME) or obstruction by the ROS defense system, resulting in poor efficacy. Therefore, enhancing the killing effect of ROS on tumors is the core of enhancing the anti‐tumor effect of PDT. In recent years, many studies have developed a series of strategies to enhance the ability of ROS to kill tumors in view of the limitations of the TME on PDT. This article summarizes the commonly used or innovative strategies in recent years, including not only frequently used methods for hypoxia in the TME but also innovative strategies to inhibit the ROS defense system. John Wiley and Sons Inc. 2020-11-03 /pmc/articles/PMC7826450/ /pubmed/33141513 http://dx.doi.org/10.1002/cam4.3592 Text en © 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Biology
Ming, Lan
Cheng, Kai
Chen, Yu
Yang, Rui
Chen, Daozhen
Enhancement of tumor lethality of ROS in photodynamic therapy
title Enhancement of tumor lethality of ROS in photodynamic therapy
title_full Enhancement of tumor lethality of ROS in photodynamic therapy
title_fullStr Enhancement of tumor lethality of ROS in photodynamic therapy
title_full_unstemmed Enhancement of tumor lethality of ROS in photodynamic therapy
title_short Enhancement of tumor lethality of ROS in photodynamic therapy
title_sort enhancement of tumor lethality of ros in photodynamic therapy
topic Cancer Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826450/
https://www.ncbi.nlm.nih.gov/pubmed/33141513
http://dx.doi.org/10.1002/cam4.3592
work_keys_str_mv AT minglan enhancementoftumorlethalityofrosinphotodynamictherapy
AT chengkai enhancementoftumorlethalityofrosinphotodynamictherapy
AT chenyu enhancementoftumorlethalityofrosinphotodynamictherapy
AT yangrui enhancementoftumorlethalityofrosinphotodynamictherapy
AT chendaozhen enhancementoftumorlethalityofrosinphotodynamictherapy